Celldex Therapeutics
Price & Volume
Stats
See moreOpen | $40.28 |
Previous Close | $40.46 |
Day Range | $39.09-$40.34 |
52W Range | $21.77-$45.14 |
Market Cap | $3.1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $158,000 |
Revenue Growth (YoY) | -97% |
Gross Profit (12 Mos) | -$278.6M |
Diluted EPS | -$4.35 |
News
See moreYahoo Finance • 2 months ago
Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval?
Yahoo Finance • 2 months ago
Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity?
Yahoo Finance • 2 months ago
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
Yahoo Finance • 2 months ago
Celldex Presents New Phase 2 CSU Data For Barzolvolimab In Angioedema; BLA Planned For 2027
About
CEO | Mr. Anthony S. Marucci M.B.A. |
CFO | Mr. Sam Martin CPA |
Address | Perryville III Building, Hampton, NJ, United States, 08827 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 198 |